novo nordisk glp-1 receptor agonist medications Novo, Lilly buoyed by fast-growing drug sales Novo's Wegovy becomes first GLP-1
Description
The trials indicated that all doses of tirzepatide resulted in greater weight loss and enhanced glycemic control in comparison to placebo
10.1038/mp.2010.80 [DOI] [PubMed] [Google Scholar] Maes M., Leonard B
doi:10.1016/j.diabres.2016.10.024 147
10.2337/db20-0095 [DOI] [PubMed] Bath K
The possibility of providing preventive regimen in multi system pathologies is a significant use of the GLP-1RA in improving disease outcomes and preventing morbidity
This risk is amplified when prescriptions are initiated through digital platforms, where in-person counseling may be limited
